Approval of Generic Fluticasone Propionate/Salmeterol Xinafoate Dry Powder Inhalers in the US: A Difficult Exercise in Regulatory Science
Crossref DOI link: https://doi.org/10.1007/s40290-014-0065-3
Published Online: 2014-08-20
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fuglsang, Anders
Text and Data Mining valid from 2014-08-01
